Skip to content

Anoudent

Active Private limited companyfounded 2016active for 10 yearsMithremstraat 19, 9940 EvergemKBO/BCE: BE 0645.783.834

Lifetime

10 annual accounts with figures on one time axis
peak of €257,731 in 2025
€257,731▲ 4.9%
peak of €188,561 in 2025
€188,561▲ 14.1%
peak of €188,956 in 2025
€188,956▲ 88.2%
€3,826▼ 96.0%
Board2 names since 2016
2 directors and 1 other
Documentsfilings and deeds
19-06-202642 days before the deadline
2025micro format
Dividend €100,000Equity from €100,395 to €188,956Debts from €94,673 to €3,826Cash from €121,327 to €175,662

Key points

from the 2025 annual accounts

Equity

€188,956 ▲ 88.2%
€100,0002024€189,0002025

Equity rose in 2025 from €100,395 to €188,956.

Turnover

≈ €390,000 estimated

The micro format states no turnover.

Investments

€34,345 1.6 times depreciation
2021202220232025

Green is investment, beige is depreciation.

Liquidity

98.14 was 4.11 in 2024

Short-term debts fell from €94,673 to €3,826.

Filings

10 annual accounts since 2016
AprilJune31 JulyOctober20202025

The last five annual accounts were filed 40 to 102 days before the end of the period.

Position in the sector

€188,561

Higher net result than 86% of companies in human health. The sector median is €59,520, over 21,372 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,817 companies had the same profile as Anoudent has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,817 companies, not a prediction for Anoudent. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
Director
  • 186 sharesdeed of 21-01-2016
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0645783834
resigns as manager reappointed as director · Discharge granted to (manager) · Gazette deed
Capital contribution: quasi-inbreng Capital €12,400, annual accounts 2016 · Gazette deed
Incorporation Founding capital of €18,550, 186 shares, €12,400 paid up · Founded by (sole founder) · appointed as sole manager · published on 21-01-2016 · Gazette deed
All 20 events

Comparable companies

same main activity, similar in size and age
Company
Anoudent Evergem €460,341 €257,731 41.0% -
Dokter Claudia Daels, gynaecologie Ghent €476,615 €227,340 95.0% -
Dr. De Cock Herzele €462,995 €251,313 91.0% -
DR. AMIT BERNAT Edegem €454,011 €263,012 30.1% -
Dr. L. Delaere, oogheelkunde Leuven €486,966 €277,306 42.9% -
DOKTER TURLOT MICHEL Brussels €502,944 €240,371 97.1% -
DR. ROGOJAN CORNELIA Heusden-Zolder €454,280 €232,539 0.5% -

These companies have the same main activity as Anoudent: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €454,000 and €503,000, founded between 2015 and 2017.

Official details

Source: KBO
Status
Active since 11-01-2016Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other
Establishment unit
2.301.158.7149940 Evergem, since 11-01-2016
Financial year end
31 December
Peppol
Reachable since 30-09-2024
Company details

Annual accounts 2025

€460,341▼ 0.1%
Filing
Filed on 19-06-2026, 42 days before the end of the filing period
Financials

Insights on Anoudent

Anoudent files the micro format. That format states no turnover. The gross margin rose from €80,276 in 2016 to €257,731 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Anoudent

What is the company number of Anoudent?
The company number of Anoudent is 0645.783.834. The VAT number is the same number with BE in front: BE 0645.783.834.
Where is Anoudent based?
The registered office is at Mithremstraat 19, 9940 Evergem.Company details
What does Anoudent do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Anoudent?
Anoudent is a private limited company (BV).
When was Anoudent founded?
Anoudent was founded on 11-01-2016.
Is Anoudent still active?
Yes, Anoudent is an active enterprise in the KBO register.
What is the turnover of Anoudent?
The turnover in financial year 2025 is about €390,000. This figure is estimated from the gross margin of €257,731 and 31 comparable companies (NACE 86220). It probably lies between €340,000 and €540,000.Financials
Is Anoudent profitable?
In financial year 2025, Anoudent made a profit of €188,561.
Where can I find the annual accounts of Anoudent?
Anoudent filed 10 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Anoudent due?
Anoudent must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.